Emmaus Life Sciences

(OTC) EMMA

Current Price$0.01

Market Cap$722.90K

Since IPO (2019)-100%

5 Year-99%

1 Year-39%

1 Month-11%

Emmaus Life Sciences Financials at a Glance

Market Cap

$722.90K

Revenue (TTM)

$12.03M

Net Income (TTM)

-$8.50M

EPS (TTM)

-$0.13

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

-0.54 (Low)

Dividend

$0.00

Beta (Volatility)

-0.54 (Low)

Price

$0.01

Volume

10,100

Open

$0.01

Price

$0.01

Volume

10,100

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

Aug 17, 2026

Dividend

$0.00

Beta (Volatility)

-0.54 (Low)

Price

$0.01

Volume

10,100

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

Aug 17, 2026

EMMA News

Emmaus Sales Drop 48 Percent

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Emmaus Life Sciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Willis C. Lee

Website

www.emmausmedical.com

Headquarters

Torrance, CA 90503, US

EMMA Financials

Key Financial Metrics (TTM)

Gross Margin

93%

Operating Margin

Net Income Margin

-71%

Return on Equity

Return on Capital

-1%

Return on Assets

-45%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$722.90K

Shares Outstanding

70.19M

Volume

10.10K

Avg. Volume

49.18K

Financials (TTM)

Gross Profit

$11.60M

Operating Income

$231.00K

EBITDA

-$310.00K

Operating Cash Flow

-$11.00K

Capital Expenditure

-$1.00K

Free Cash Flow

-$12.00K

Cash & ST Invst.

$2.13M

Total Debt

$32.56M

Emmaus Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$1.98M

-17.6%

Gross Profit

$1.81M

-16.8%

Gross Margin

91.52%

N/A

Market Cap

$722.90K

N/A

Market Cap/Employee

$21.26K

N/A

Employees

N/A

Net Income

-$3.34M

-43.1%

EBITDA

-$808.00K

+24.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$1.07M

-19.6%

Total Debt

$31.96M

-3.1%

Accounts Receivable

$2.05M

-0.6%

Inventory

$1.91M

+32.8%

Long Term Debt

$3.60M

+28.8%

Short Term Debt

$28.36M

-6.0%

Return on Assets

-45.45%

N/A

Return on Invested Capital

-0.75%

N/A

Free Cash Flow

-$344.00K

-223.3%

Operating Cash Flow

-$344.00K

-223.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NPHCNutra Pharma Corp.

NPHCNutra Pharma Corp.$0.00-75.00%

SQZBSQZ Biotechnologies Company

SQZBSQZ Biotechnologies Company$0.02+0.00%

HXBMHelix BioMedix, Inc.

HXBMHelix BioMedix, Inc.$1.79+0.00%

BPTHBio-Path Holdings, Inc.

BPTHBio-Path Holdings, Inc.$0.04-6.54%

YECOYulong Eco-Materials Limited

YECOYulong Eco-Materials Limited$0.02+0.00%

VPROViropro Inc.

VPROViropro Inc.$0.00+0.00%

ORGSOrgenesis Inc.

ORGSOrgenesis Inc.$0.50+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

INTCIntel

INTCIntel$124.57+0.07%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About EMMA

What is the current price of Emmaus Life Sciences?

Emmaus Life Sciences is trading at $0.01 per share.

What is the 52-week range for Emmaus Life Sciences?

Over the past 52 weeks, Emmaus Life Sciences has traded between $0.01 and $0.02.

How much debt does Emmaus Life Sciences have?

As of the most recent reporting period, Emmaus Life Sciences reported total debt of $31.96M.

How much cash does Emmaus Life Sciences have on hand?

Emmaus Life Sciences reported $1.07M in cash and cash equivalents in its most recent financial results.

What is Emmaus Life Sciences’s dividend yield?

Emmaus Life Sciences does not currently have a dividend yield.

Emmaus Life Sciences

Emmaus Life Sciences Financials at a Glance

EMMA News

Emmaus Sales Drop 48 Percent

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Emmaus Life Sciences

EMMA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Emmaus Life Sciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EMMA

What is the current price of Emmaus Life Sciences?

What is the 52-week range for Emmaus Life Sciences?

How much debt does Emmaus Life Sciences have?

How much cash does Emmaus Life Sciences have on hand?

What is Emmaus Life Sciences’s dividend yield?

Premium Investing Services